High-Sensitivity C-Reactive Protein
The most widely studied circulating inflammatory marker in cardiovascular epidemiology.
Primary Biological Role: Opsonin synthesized by hepatocytes in response to IL-6 stimulation, facilitating phagocytosis of dead cells.
Evidence Score
Evidence Dimension Breakdown
Overview
High-Sensitivity C-Reactive Protein (hs-CRP) is the most widely studied circulating inflammatory marker in cardiovascular epidemiology, though it is non-specific as to the source of inflammation. Unlike standard CRP assays used for detecting major infections, hs-CRP assays measure low-grade basal inflammation. The 2003 CDC/AHA scientific statement described hs-CRP tiers of <1.0, 1.0–3.0 and >3.0 mg/L as an optional adjunct to conventional risk factors in people at intermediate risk, and did not recommend hs-CRP screening of the general population.
Biological Mechanism
When upstream inflammatory cytokines—primarily Interleukin-6 (IL-6)—are released into circulation, they stimulate hepatic transcription of CRP. CRP acts as an innate immune pattern-recognition molecule, binding to phosphocholine on damaged cell membranes and microbial pathogens to activate the classical complement pathway and recruit phagocytes.
Clinical Trial & Outcome Evidence
Backed by hundreds of prospective cohort studies and massive randomized trials including the JUPITER trial (n=17,802) and CANTOS (n=10,061). hs-CRP predicts cardiovascular events, but whether lowering CRP itself changes outcomes has not been established: the drugs that lower it also act on other pathways — statins on LDL, canakinumab on IL-1β signalling.
Analytical Limitations & Confounders
hs-CRP is synthesized by the liver and is completely non-specific to tissue source. It transiently spikes by orders of magnitude during acute viral or bacterial illness, minor physical trauma, or strenuous unaccustomed exercise. Furthermore, baseline levels are associated with body mass index and adiposity, particularly visceral adipose tissue, which secretes the IL-6 that drives hepatic CRP synthesis.
Kinetics & Retesting Frequency
Hepatic CRP synthesis begins approximately 6–8 hours following an inflammatory trigger and peaks around 48 hours. Following resolution of the inflammatory stimulus, circulating CRP levels decline with a plasma half-life of ~19 hours, making it suitable for tracking multi-week therapeutic interventions. Within-subject coefficient of variation is high — median 44%, range 27–76% (Gough 2024, PMID 39485740) — so two measurements at least two weeks apart should be averaged.
Frequently Asked Questions
What does an elevated hs-CRP result mean, and what can raise it apart from cardiovascular risk?
An elevated hs-CRP indicates an active systemic acute-phase response, but it is non-specific as to the underlying anatomical source or etiology. Beyond cardiovascular risk, hs-CRP is raised by acute viral or bacterial infections, minor physical trauma, recent strenuous exercise, and adiposity—particularly visceral fat, which secretes IL-6 driving hepatic CRP synthesis. A single elevated reading should not be interpreted in isolation; guidelines recommend confirming with a second measurement at least two weeks apart when metabolically stable.
How often should hs-CRP be measured to track a wellness protocol?
Because hs-CRP has a ~19-hour half-life but reflects multi-week metabolic shifts, measuring it every 4 to 8 weeks provides an assessment of whether an intervention is dampening basal vascular inflammation. Serial measurements should be read against its high within-subject biological variability.
Biomarker Profile
- Class
- Acute-Phase Reactant
- Score
- 82/100
- Grade
- A−
Key Published Studies
- [1] JUPITER Trial — NEJM 2008 PMID: 18997196
- [2] CANTOS Trial — NEJM 2017 PMID: 28845751
- [3] AHA/CDC Scientific Statement on Inflammation Markers — Circulation 2003 PMID: 12551878
- [4] Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease — J Clin Invest 1993 PMID: 8473487
Related Biomarkers
Related Panel Patterns
Track Your Inflammation — Cohort Now Forming
Track your own inflammatory gene expression over time. Reserve your spot in the Inflammation Compass founding cohort today to lock in early pricing before the general public.